ID: ALA80004

Max Phase: Preclinical

Molecular Formula: C30H33FN8O4S

Molecular Weight: 620.71

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCCOc1ccc(S(=O)(=O)N2CC[C@@H](N(C)C)C2)cc1-c1nc(O)c2c(NCc3ccc(F)cc3)[nH]c3nncc-3c2n1

Standard InChI:  InChI=1S/C30H33FN8O4S/c1-4-13-43-24-10-9-21(44(41,42)39-12-11-20(17-39)38(2)3)14-22(24)27-34-26-23-16-33-37-28(23)35-29(25(26)30(40)36-27)32-15-18-5-7-19(31)8-6-18/h5-10,14,16,20H,4,11-13,15,17H2,1-3H3,(H,34,36,40)(H2,32,33,35,37)/t20-/m1/s1

Standard InChI Key:  AHPXICLKUGGTTI-HXUWFJFHSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 620.71

Molecular Weight (Monoisotopic): 620.2330

AlogP: 4.09

#Rotatable Bonds: 10

Polar Surface Area: 149.46

Molecular Species: NEUTRAL

HBA: 10

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 12

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 7.77

CX Basic pKa: 8.12

CX LogP: 2.95

CX LogD: 2.77

Aromatic Rings: 3

Heavy Atoms: 44

QED Weighted: 0.21

Np Likeness Score: -1.64

References

1. Bi Y, Stoy P, Adam L, He B, Krupinski J, Normandin D, Pongrac R, Seliger L, Watson A, Macor JE..  (2001)  The discovery of novel, potent and selective PDE5 inhibitors.,  11  (18): [PMID:11549447] [10.1016/s0960-894x(01)00466-8]

Source

Source(1):

• Scientific Literature